Neurohacker Collective

Neurohacker Collective is a biotechnology startup, founded in 2015 with the aim of revolutionizing human optimization and longevity. The company's pioneering approach, rooted in complex systems science, sets it apart in the industry. Instead of relying on traditional methods, Neurohacker Collective leverages a unique methodology to research and development, focusing on supporting the body’s natural ability to self-regulate. This approach, in contrast to chemical intervention, prioritizes overall well-being and peak performance.

Since its inception, Neurohacker Collective has gained recognition for its Qualia nootropic line, which is just the beginning of a comprehensive product portfolio designed to enhance cognitive function and well-being. The company's commitment to holistic solutions is underlined by its recent Convertible Note investment at 21 March 2019, which was backed by JVMO and Maximus Richardson, showcasing investor confidence in its vision and potential.

Neurohacker Collective's ongoing journey to pioneer revolutionary advancements in human optimization and longevity positions it as an intriguing prospect for potential venture capital partnerships, especially for investors with a keen interest in the intersection of biotechnology and complex systems science.